Phillip Febbo
Chief Tech/Sci/R&D Officer bei VERACYTE, INC.
Vermögen: 4 Mio $ am 31.03.2024
Profil
Phillip G. Febbo ist Chief Medical Officer von Illumina, Inc. Er ist außerdem Mitglied des Vorstands von Varian Medical Systems, Inc. sowie des American College of Medical Genetics & Genomics und der Acmg Foundation For Genetic & Genomic Medicine und Mitglied der American Society for Clinical Investigation. In seiner bisherigen Laufbahn war Dr. Febbo Chief Medical Officer bei Genomic Health, Inc. sowie außerordentlicher Professor an der Duke University und Professor an der University of California, San Francisco. Phillip G. Febbo erwarb einen Bachelor-Abschluss am Dartmouth College und einen Doktortitel an der University of California, San Francisco.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
VERACYTE INC
0,12% | 06.03.2024 | 93 086 ( 0,12% ) | 2 Mio $ | 31.03.2024 |
ILLUMINA, INC.
0,01% | 17.04.2023 | 14 786 ( 0,01% ) | 2 Mio $ | 31.03.2024 |
Aktive Positionen von Phillip Febbo
Unternehmen | Position | Beginn |
---|---|---|
VERACYTE, INC. | Chief Tech/Sci/R&D Officer | 02.10.2023 |
American Society for Clinical Investigation
American Society for Clinical Investigation BiotechnologyHealth Technology American Society for Clinical Investigation engages as a medical honor society. It focuses on physician-scientists in research, clinical care, and medical education. The company was founded by Samuel J. Meltzer in 1908 and is headquartered in Ann Arbor, MI. | Corporate Officer/Principal | 01.01.2009 |
American College of Medical Genetics & Genomics | Director/Board Member | 01.01.2018 |
Acmg Foundation For Genetic & Genomic Medicine | Director/Board Member | - |
Ehemalige bekannte Positionen von Phillip Febbo
Unternehmen | Position | Ende |
---|---|---|
ILLUMINA, INC. | Chief Tech/Sci/R&D Officer | 07.08.2023 |
VARIAN MEDICAL SYSTEMS, INC. | Director/Board Member | 15.04.2021 |
GENOMIC HEALTH, INC. | Chief Tech/Sci/R&D Officer | 01.03.2018 |
The University of California, San Francisco | Corporate Officer/Principal | 01.01.2013 |
Duke University
Duke University Other Consumer ServicesConsumer Services Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC. | Corporate Officer/Principal | - |
Ausbildung von Phillip Febbo
Dartmouth College | Undergraduate Degree |
The University of California, San Francisco | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
ILLUMINA, INC. | Health Technology |
VERACYTE, INC. | Health Technology |
Private Unternehmen | 4 |
---|---|
Varian Medical Systems, Inc.
Varian Medical Systems, Inc. Medical SpecialtiesHealth Technology Varian Medical Systems, Inc. engages in the manufacture of medical devices and software for treating cancer and other medical conditions. It operates through the Oncology Systems and Proton Solutions segments. The Oncology Systems segment designs, manufactures, sells, and services hardware and software products for treating cancer with conventional radiation therapy, and advanced treatments. The Proton Solutions segment delivers proton therapy, a form of external beam radiotherapy using proton beams for the treatment of cancer. The company was founded by William Hansen, Edward Ginzton, Russell Varian, and Sigurd Varian in 1948 and is headquartered in Palo Alto, CA. | Health Technology |
Genomic Health, Inc.
Genomic Health, Inc. Medical SpecialtiesHealth Technology Genomic Health, Inc. engages in the provision of genomic-based diagnostic tests. Its tests analyze the underlying biology of cancers, allowing physicians and patients to make individualized treatment decisions. The firm uses a platform which translates a massive amount of clinical and genomic data into clinically actionable results for treatment planning. The company was founded by Patrick F. Terry, Joffre B. Baker, Randal W. Scott, and Steven Shak in August 2000 and is headquartered in Redwood City, CA. | Health Technology |
American Society for Clinical Investigation
American Society for Clinical Investigation BiotechnologyHealth Technology American Society for Clinical Investigation engages as a medical honor society. It focuses on physician-scientists in research, clinical care, and medical education. The company was founded by Samuel J. Meltzer in 1908 and is headquartered in Ann Arbor, MI. | Health Technology |
Acmg Foundation For Genetic & Genomic Medicine | Miscellaneous |